Abstract Since 1989, a large number of mutations of the tyrosinase gene, which result in oculocutaneous albinism (OCA), have been reported. However, approximately 15% of patients with tyrosinase-related OCA (OCA1) heterozygously carried an uncharacterized mutation, which presumably existed outside of the ordinarily examined area of the tyrosinase gene. In such cases, polymorphic sequence(s) of the tyrosinase gene might be useful to identify the OCA1 allele. In this study, we examined four polymorphic sequences of the tyrosinase gene in 16 patients with OCA1, their relatives, and 108 normally pigmented Japanese individuals. The results showed a complex dinucleotide repeat in the promoter region at Ϫ800 to Ϫ900 of seven different lengths, and a polythymidine sequence in the 3Ј end of intron 2 of three different lengths. Polymerase chain reaction-restriction fragment length polymorphism analysis of two polymorphic sequences at Ϫ301 (C/T) and Ϫ199 (C/A) in the promoter region allows us to classify the tyrosinase gene into three groups. Using these polymorphic sequences, we could identify the OCA1 allele in more than 80% of cases in which the parents' genomic DNA was available. Three polymorphic sequences in the tyrosinase gene promoter are particularly useful for this purpose.
Introduction
Oculocutaneous albinism (OCA) is an autosomal recessive inherited disorder characterized by the reduced or absent biosynthesis of melanin pigment in melanocytes of the skin, hair follicles, and eyes (King et al. 1995) . Until now, three different genes were identified as responsible for OCA1, 2, and 3. Tyrosinase-related OCA (OCA1) results from deficient activity of tyrosinase, which is an essential enzyme of melanin biosynthesis (Lerner et al. 1949) . In tyrosinasenegative OCA (OCA1A), tyrosinase activity and melanin biosynthesis are completely absent, and in yellow mutant OCA (OCA1B), tyrosinase activity and melanin biosynthesis are greatly reduced. OCA2 and OCA3 are caused by homozygous gene mutations of P-protein and tyrosinaserelated protein 1 (TRP1; DHICA oxidase), respectively . Because of no tyrosinase gene mutation, patients with OCA2 and OCA3 have enough tyrosinase activity, and their skin, hair, and eyes are a little pigmented. Therefore they are clinically distinguishable from patients with OCA1, who show no pigment.
The human tyrosinase gene, encoding a 58-kD a glycoprotein composed of 529 amino acids (Shibahara et al. 1988; Takeda et al. 1989) , consists of five exons spanning more than 50kb of DNA in chromosome 11q14-q21 (Barton et al. 1988) . In 1989, we reported, for the first time, a pathologic mutation of the tyrosinase gene in a patient with OCA1A . Since then, a large number of tyrosinase gene mutations associated with OCA1 have been reported (Oetting 2000) . In addition to pathological mutations, several polymorphic sequences of the tyrosinase gene were reported (Figure 1 ). In 1991, Morris et al. showed that a complex dinucleotide (guanine and adenine, GA) repeat located 800-900 bp upstream of the protein-coding region of the tyrosinase gene could be classified into five different lengths in 31 unrelated individuals (Morris et al. 1991) . Other polymorphic sequences in the promoter were located 301 (cytosine or thymine, C/T) and 199 (adenine or cytosine, A/C) bp, respectively, upstream of the protein-coding region (Oetting and King 1993; Oetting et al. 1991 ). In the protein-coding region, two polymorphic sites (codon 192 and 402) have been identified (Giebel and Spritz 1990; Tripathi et al. 1991) ; however, in our experience, these sites are not polymorphic in the Japanese population.
Sequence analysis of the tyrosinase gene became a routine way to diagnose patients with OCA1 in several laboratories. However, approximately 15% of the patients heterozygously carried an uncharacterized mutation (UCM), which presumably existed outside of the ordinarily examined area of the tyrosinase gene (King et al. 1995) . In our laboratory, we usually examined the protein-coding region, exon/intron junctions, and the proximal promoter region (up to 379 bp from the coding region) of the tyrosinase gene (Matsunaga et al. 1998 ). For one patient (Patient 4 in Table 1 ) with the OCA1A phenotype, who heterozygously carried the R77Q mutation, we further sequenced the patient's tyrosinase gene from the protein-coding region up to position Ϫ2114 in the promoter region (Matsunaga et al. 1997 ). We could not find any pathological mutations, including a tyrosinase distal element (TDE), a strong enhancer for pigment cell-specific expression that exists 1.8 kb upstream of the transcription initiation site of the tyrosinase gene (Yasumoto et al. 1994 ). However, we found a difference between the two OCA1 alleles in the GA repeat region. This finding led us to consider the use of the polymorphic sequences of the tyrosinase gene to identify OCA1 alleles.
To explore the possibility of indirect gene analysis for the diagnosis of OCA1, we examined three polymorphic sequences in the tyrosinase gene promoter and the polythymidine sequence in the 3Ј end of intron 2 in 16 patients with OCA1, their relatives, and 108 normally pigmented Japanese individuals.
Materials and methods

Patients
Sixteen Japanese patients with OCA1 were included (Table  1 ). Mutation analysis of the patients 1 (Takeda et al. 1990 ), 4 (Matsunaga et al. 1997) , 5 (Takizawa et al. 2000) , 6 , 11 and 12 (Matsunaga et al. 1996) , 13 (Matsunaga et al. 1998 ), 14 (Matsunaga et al. 1999) , 15 (Nakamura et al. 2001) , and 16 have been reported previously. Patients 4 and 5 heterozygously carried a UCM (Table 1) . We clinically diagnosed patient 4 as having OCA1A because she had a typical OCA1A phenotype, showing no pigment in the skin, hair, and eyes. Although we could not exclude the possibility that patient 5 had OCA2 or OCA3, we thought that the existence of the R77Q mutation in her tyrosinase gene suggested an association with OCA1 rather than a coincidence with homozygous mutations of P-protein gene or TRP1 gene.
The patients and all subjects enrolled in this study provided informed consent. This study was approved by the Ethical Committee of Nagoya University Graduate School of Medicine.
Preparation of genomic DNA Peripheral blood, collected from the patients, their relatives, and phenotypically normal Japanese individuals were used as sources of genomic DNA. We extracted genomic DNA using QIAGEN Blood DNA Kits (QIAGEN, Valencia, CA, USA).
Length analysis for the complex dinucleotide (GA) repeat
The genomic DNA segment containing the region concerned was amplified by polymerase chain reaction (PCR) using ExTaq (TaKaRa, Kyoto, Japan), electrophoresed on an ABI 373A Sequencer (Perkin-Elmer/Applied Biosystems Division, Foster City, CA, USA), and analyzed for length using ABI GeneScan software. The primers used and the PCR conditions were 5-AGGAAAAACAATATG GCTACAGCATT-3 (TDS4), 5-CCTGATGCATTTTCT GACAACTCC-3 (TDS4R), with an initial heating for 1 min at 94°C, 30 cycles for 20 sec at 98°C and 1min at 65°C, and with a final elongation step for 10 min at 72°C. The genomic DNA segment was amplified by PCR using TaKaRa Taq (TaKaRa). The primers used and the PCR conditions were 5-GCTTAGGTCAGGCATTATTATTA CTGA-3 (222P), 5-ATAATACCACTCCCACCTCCA GC-3 (120PR), 30 cycles for 1 min at 98°C, 2 min at 65°C, and 3 min at 72°C. The amplified products were respectively digested with Mbo I for Ϫ301 (C/T) or Sfu I for Ϫ199 (C/A), and electrophoresed on a 5% polyacrylamide gel.
Length analysis of the 3Ј end of intron 2
The genomic DNA segment was amplified by PCR under the same conditions as described for the complex dinucleotide (GA) repeat, except that the primers used were 5-GTAAAGAGTCTCAATACGGAATGAAT-3 (dTTF) and 5-GGCATTGTGCATGCTGCTTTGAG-3 (dTT4).
Results
Genotype and allele analysis of the tyrosinase gene in the 16 OCA1 patients and their relatives Table 1 summarizes the results of genotype analysis for the OCA1 patients and their relatives examined in this study. We identified 20 different alleles of the tyrosinase gene, as shown in Table 2 . Two polymorphic sequences at Ϫ301 (C/T) and Ϫ199 (C/A) in the promoter region allowed us to classify the tyrosinase gene into three groups, C-C, T-C, and T-A.
Possibility of indirect gene diagnosis from three polymorphic sequences in the tyrosinase promoter We tried to examine whether allele analysis of the tyrosinase gene was useful for identifying an OCA1 allele in our cases. Eleven of the 16 cases in which parents' samples were available were subjected to the analysis. As shown in Table  3 , in 9 of 11 cases, we were able to diagnose possible sibling haplotypes and various combinations of alleles for those of affected, carrier, or noncarrier status from the allele analysis of the three polymorphic sequences of the patients and their parents.
Polymorphic sequences of the tyrosinase gene in normally pigmented Japanese individuals
The frequency and observed heterozygosity for each polymorphic sequence examined in 108 unrelated normally pigmented Japanese individuals are summarized in Table 4 . We found a novel genotype of intron 2, noted as 210 in Table 4 . Sequence analysis from 10 individuals showed that this genotype corresponded to an insertion of thymidine into a poly-thymidine sequence (position Ϫ21 to Ϫ27 from exon 3) without exception (data not shown). Table 5 presents the estimated haplotype frequencies in the Japanese population using the EH program (Terwilliger and Ott 1994; Curtis and Sham 1995) .
Discussion
At present, over 90 mutations of the tyrosinase gene associated with OCA1 have been described (Oetting 2000) , and common mutations occur by ethnic group. For example, the P81L and T373K were observed in 25%-30% of northern Europeans (Spritz 1993; Spritz et al. 1997) , and the R77Q and 929insC (P310insC) are common in Korean (Park et al. 1996 (Park et al. , 1997 and Japanese individuals . Patients 1 to 3, who were homozygous for the R77Q mutation, showed single haplotype combination 359-C-C-209. Although patients 4 and 5 were heterozygous for the R77Q mutation, genotype data of the parents indicated that the R77Q mutation and the 359-C-C-209 moved together. Therefore, we concluded that R77Q mutation was associated with haplotype 359-C-C-209 in 5 cases (8 chromosomes). In the same way, the data on five homozygous cases (patients 6 to 10) and 5 heterozygous cases (patients 11, 12, 14, 15, and 16) for the 929insC mutation in Table 1 suggested that the 929insC mutation was primarily associated with haplotype 357-C-C-209 in 10 cases (15 chromosomes). Therefore, we presumed that the R77Q and 929insC mutations derived from a common origin (founder), respectively. On the assumption that associations of the 359-C-C-209-R77Q and 357-C-C-209-929insC had no exception, we identified 20 alleles of the tyrosinase gene, as shown in Table 2 . Interestingly, the R278X mutation was associated with two haplotypes, 357-T-C-209 and 359-T-A-209. This fact suggested that the R278X mutation had two different origins, or occurred in a very ancient era. The R278X mutation was observed in various ethnic groups other than the Japanese population, such as Guayanan (Tripathi et al. 1993 ), Moroccan Jew (Gershoni-Baruch et al. 1994) , and Indo-Pakistani (paper in preparation). Allele frequencies of the polymorphic sequence at Ϫ199 (C for 0.898 and A for 0.102, as shown in Table 4 ) in Japanese individuals were virtually the same as those in Caucasians (C for 0.893 and A for 0.107) and Orientals (C for 0.887 and A for 0.113) (Oetting et al. 1991) . Therefore, a base substitution of A for C at Ϫ199 presumably occurred long before humans divided into Caucasians and Orientals. We speculate that C at Ϫ301 and C at Ϫ199 (C-C) is a probable candidate for the ancestral haplotype of the human tyrosinase gene. During evolution of the human tyrosinase gene, two mutations occurred. The first appeared in a C-C allele, where a base substitution of T for C at Ϫ301 Because there was overwhelming evidence for association between markers ( 2 ϭ 200.38, P Ͻ 0.0001), haplotype frequencies under the hypothesis of allelic association were shown resulted in a T-C allele. The second mutation probably took place in a T-C allele. The estimated allele frequencies in the Japanese population were 0.671 for C-C, 0.227 for T-C, and 0.102 for T-A.
Recently, there has been increased awareness of and attention paid to genetic diseases. Identification of prevalent and/or novel mutations of the tyrosinase gene will facilitate the DNA-based diagnosis for OCA1. Haplotype analysis is a classical way to identify pathological alleles, although allele analysis of the tyrosinase gene is still useful under certain situations, and tells us the origin of the mutated allele.
